Table 2.
The growth responses (SDS) of patients with PSIS or transient GHD to GH treatment
| SDS | PSIS | Transient GHD | P |
| (n = 53) | (n = 19) | ||
| First year | |||
| Growth rate | 3.8 ± 2.6 | 1.3 ± 2.2 | 0.0007 |
| Height change | 1.2 ± 1.0 | 0.48 ± 0.7 | <0.0001 |
| Second year | |||
| Growth rate | 1.8 ± 2.4 | 0.26 ± 1.3 | 0.006 |
| Height change | 0.47 ± 0.5 | 0.18 ± 0.3 | <0.03 |
| Third year | |||
| Growth rate | 0.77 ± 1.7 | 0.05 ± 1.3 | NS |
| Height change | 0.2 ± 0.4 | 0.14 ± 0.3 | NS |
| Height change over three years | 1.9 ± 1.1 | 0.8 ± 1.0 | 0.0002 |
| (n = 30) | (n = 12) | ||
| Adult height | -1.0 ± 0.9 | -1.8 ± 0.8 | <0.02 |
| Height change from diagnosis | 1.7 ± 1.2 | 1.08 ± 0.8 | 0.05 |
| Mean ± SD | |||